Posted in | News | Plastics and Polymers

Metabolix to Manufacture Mirel Biopolymers at Antibióticos’ Plant in Spain

Metabolix, a provider of sustainable solutions to energy, chemicals and plastics industries, has entered into an agreement with Antibióticos, a producer of Active Pharmaceutical Ingredients (APIs), for manufacture of Mirel biopolymer resin. Under the terms of the agreement, Metabolix will produce its Mirel biopolymers at Antibióticos’ manufacturing plant in Leon, Spain.

Metabolix and Antibióticos will perform a sequence of validation production runs to show fermentation and recovery of Mirel materials on Antibióticos’ full production-scale equipment. Metabolix will possess the Mirel resins that are manufactured in the validation production runs. The company has planned to sign a definitive manufacturing agreement with Antibióticos based on the validation production runs and after the completion of engineering and economic feasibility studies.

Biopolymers from Metabolix are based on polyhydroxyalkanoates (PHA) that occur naturally in plants and micro-organisms. Mirel biopolymer resins are biobased, biodegradable and ideal for a broad range of applications. The company is now delivering the resin to clients from existing inventory of about 5 million pounds.

Richard P. Eno, President and CEO of Metabolix, stated that the partnership with Antibióticos signifies a considerable progress in setting up a new supply chain for Mirel biopolymer resin to better serve their customers globally and to continue product development. Additionally, Antibióticos is located in the EU near many of Metabolix’s targeted customers and they believe that Antibioticos’ technical expertise, facilities and equipment are ideal for manufacturing Mirel biopolymers at commercial scale, concluded Eno.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Yield10 Bioscience, Inc.. (2019, February 09). Metabolix to Manufacture Mirel Biopolymers at Antibióticos’ Plant in Spain. AZoM. Retrieved on October 12, 2024 from https://www.azom.com/news.aspx?newsID=33686.

  • MLA

    Yield10 Bioscience, Inc.. "Metabolix to Manufacture Mirel Biopolymers at Antibióticos’ Plant in Spain". AZoM. 12 October 2024. <https://www.azom.com/news.aspx?newsID=33686>.

  • Chicago

    Yield10 Bioscience, Inc.. "Metabolix to Manufacture Mirel Biopolymers at Antibióticos’ Plant in Spain". AZoM. https://www.azom.com/news.aspx?newsID=33686. (accessed October 12, 2024).

  • Harvard

    Yield10 Bioscience, Inc.. 2019. Metabolix to Manufacture Mirel Biopolymers at Antibióticos’ Plant in Spain. AZoM, viewed 12 October 2024, https://www.azom.com/news.aspx?newsID=33686.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.